Vaccine Funding Tied to Liability
Trial Lawyers Say Move Would Hurt Consumers
By Jeffrey H. Birnbaum
Washington Post Staff Writer
Thursday, November 17, 2005; Page D01
Legislation that would pour billions of dollars into the production of vaccines against avian flu and other pandemic diseases is threatened by the trial lawyers' lobby, which objects to proposed limits onlawsuits against drug manufacturers.
Republican congressional leaders, acting at the urging of President Bush, hope to approve a measure soon that would appropriate about $7 billion to pay for vaccines that would combat a flu epidemic and biological attacks by terrorists. The bill could begin moving on Capitol Hill this week.
But the Association of Trial Lawyers of America and some of its Democratic allies in Congress are working to scuttle or drastically transform the effort, asserting that anti-lawsuit language in the bill would so broadly indemnify pharmaceutical companies against suits that consumers' rights would be denied.
Sen. Judd Gregg (R-N.H.), the Senate's chief advocate for strict liability protections, asserted that the companies need to be thoroughly indemnified against suits to provide enough of an incentive for them to make vaccines, which tend to be low-profit products.
The conflict will almost certainly lead to fireworks during debate on the floor of the House and the Senate and could delay the legislation itself, which is a Bush priority, lobbyists and congressional aides said....
http://www.washingtonpost.com/wp-dyn/content/article/2005/11/16/AR2005111602238.html